If a connection between surgical pressure and prostate cancer progression is verified, preoperative inhibition of b-adrenergic signaling can improve efficacies of androgen ablation therapies
The AR antagonist MDV3100 is a much more strong inhibitor of AR purpose than bicalutamide since in addition to competing with androgens it stops AR nuclear localization and DNA binding…